206 related articles for article (PubMed ID: 28795417)
21. Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach.
Fromont G; Chene L; Latil A; Bieche I; Vidaud M; Vallancien G; Mangin P; Fournier G; Validire P; Cussenot O
J Urol; 2004 Oct; 172(4 Pt 1):1382-5. PubMed ID: 15371850
[TBL] [Abstract][Full Text] [Related]
22. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
23. Enhanced prostatic Esr1
Sharkey C; Long X; Al-Faouri R; Strand D; Olumi AF; Wang Z
J Pathol; 2024 Jul; 263(3):300-314. PubMed ID: 38606616
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
Liu Q; Zhu Y; Liu J; Qi J; Kang J
Int Urol Nephrol; 2017 Mar; 49(3):399-404. PubMed ID: 27987130
[TBL] [Abstract][Full Text] [Related]
25. Telomerase Activity and Telomere Length in Human Benign Prostatic Hyperplasia Stem-like Cells and Their Progeny Implies the Existence of Distinct Basal and Luminal Cell Lineages.
Rane JK; Greener S; Frame FM; Mann VM; Simms MS; Collins AT; Berney DM; Maitland NJ
Eur Urol; 2016 Apr; 69(4):551-554. PubMed ID: 26455356
[TBL] [Abstract][Full Text] [Related]
26. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
27. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia.
O'Malley KJ; Eisermann K; Pascal LE; Parwani AV; Majima T; Graham L; Hrebinko K; Acquafondata M; Stewart NA; Nelson JB; Yoshimura N; Wang Z
Prostate; 2014 Jun; 74(8):892-900. PubMed ID: 24711254
[TBL] [Abstract][Full Text] [Related]
29. Unique features of the basal cells of human prostate epithelium.
El-Alfy M; Pelletier G; Hermo LS; Labrie F
Microsc Res Tech; 2000 Dec; 51(5):436-46. PubMed ID: 11074614
[TBL] [Abstract][Full Text] [Related]
30. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
[TBL] [Abstract][Full Text] [Related]
31. Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.
Middleton LW; Shen Z; Varma S; Pollack AS; Gong X; Zhu S; Zhu C; Foley JW; Vennam S; Sweeney RT; Tu K; Biscocho J; Eminaga O; Nolley R; Tibshirani R; Brooks JD; West RB; Pollack JR
JCI Insight; 2019 May; 5(12):. PubMed ID: 31094703
[TBL] [Abstract][Full Text] [Related]
32. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer.
Habermann H; Ray V; Habermann W; Prins GS
J Urol; 2001 Dec; 166(6):2267-72. PubMed ID: 11696749
[TBL] [Abstract][Full Text] [Related]
33. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
34. Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67.
Yang XJ; McEntee M; Epstein JI
Hum Pathol; 1998 Dec; 29(12):1447-50. PubMed ID: 9865831
[TBL] [Abstract][Full Text] [Related]
35. Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
Inamura S; Shinagawa T; Hoshino H; Sakai Y; Imamura Y; Yokoyama O; Kobayashi M
Prostate; 2017 May; 77(7):794-802. PubMed ID: 28181681
[TBL] [Abstract][Full Text] [Related]
36. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
Trachtenberg J
BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
[TBL] [Abstract][Full Text] [Related]
37. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression.
Montironi R; Mazzucchelli R; Stramazzotti D; Scarpelli M; López Beltran A; Bostwick DG
J Clin Pathol; 2005 Mar; 58(3):290-6. PubMed ID: 15735163
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
39. Smoking Is Associated With Basal Cell Hyperplasia on Prostate Biopsy Specimens.
Freitas DM; Andriole GL; Freedland SJ; Neto BS; Moreira DM
Am J Clin Pathol; 2021 Oct; 156(5):934-938. PubMed ID: 33939794
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
Dema A; Tudose N
Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]